Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma von Feun, Lynn G., Li, Ying‐Ying, Wu, Chunjing, Wangpaichitr, Medhi, Jones, Patricia D., Richman, Stephen P., Madrazo, Beatrice, Kwon, Deukwoo, Garcia‐Buitrago, Monica, Martin, Paul, Hosein, Peter J., Savaraj, Niramol

Volltext

Levels of Symptom Burden During Chemotherapy for Advanced Lung Cancer: Differences Between Public Hospitals and a Tertiary Cancer Center von CLEELAND, Charles S, MENDOZA, Tito R, LU, Charles, WANG, Xin Shelley, WOODRUFF, Jeanie F, PALOS, Guadalupe R, RICHMAN, Stephen P, NAZARIO, Arlene, LYNCH, Garrett R, LIAO, Kai-Ping, MOBLEY, Gary M

Volltext

Pain Education for Underserved Minority Cancer Patients: A Randomized Controlled Trial von ANDERSON, Karen O, MENDOZA, Tito R, KALISH, Dorianne, CLEELAND, Charles S, PAYNE, Richard, VALERO, Vicente, PALOS, Guadalupe R, NAZARIO, Arlene, RICHMAN, Stephen P, HURLEY, Judith, GNING, Ibrahima, LYNCH, Garrett R

Volltext

Cancer pain management among underserved minority outpatients: Perceived needs and barriers to optimal control von ANDERSON, Karen O, RICHMAN, Stephen P, HURLEY, Judith, PALOS, Guadalupe, VALERO, Vicente, MENDOZA, Tito R, GNING, Ibrahima, CLEELAND, Charles S

Volltext

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma von Feun, Lynn G, Wangpaichitr, Medhi, Li, Ying-Ying, Kwon, Deukwoo, Richman, Stephen P, Hosein, Peter J, Savaraj, Niramol

Volltext

Phase II trial of SOM230 in patients with unresectable hepatocellular carcinoma (HCC) von Feun, Lynn G., Savaraj, Niramol, Wangpaichitr, Medhi, Richman, Stephen P., Kwon, Deukwoo, Dinh, Vy, Martin, Paul

Volltext

Phase II study of pembrolizumab in advanced, unresectable hepatocellular carcinoma von Feun, Lynn G., Li, Ying-Ying, Wangpaichitr, Medhi, Jones, Patricia Denise, Richman, Stephen P., Madrazo, Beatrice, Kwon, Deukwoo, Martin, Paul, Hosein, Peter Joel, Savaraj, Niramol

Volltext

Minority cancer patients and their providers : Pain management attitudes and practice von ANDERSON, K. O, MENDOZA, T. R, CLEELAND, C. S, VALERO, V, RICHMAN, S. P, RUSSELL, C, HURLEY, J, DELEON, C, WASHINGTON, P, PALOS, G, PAYNE, R

Volltext

Phase II trial of 4′‐O‐tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinoma von Sridhar, Kasi S., Hussein, Atif M., Benedetto, Pasquale, Ardalan, Bach, Savaraj, Niramol, Richman, Stephen P.

Volltext

Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia von GUCALP, R, RITCH, P, WIERNIK, PH, SARMA, PR, KELLER, A, RICHMAN, SP, TAUER, K, NEIDHART, J, MALLETTE, LE, SIEGEL, R, VANDEPOL, CJ

Volltext

A phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma von Morrell, Louise E., Lee, Young J., Hurley, Judith, Arias, Mayda, Mies, Carolyn, Richman, Stephen P., Fernandez, Hugo, Donofrio, Kim A., Raub, William A., Cassileth, Peter A.

Volltext

Cancer pain management among underserved minority outpatients von Anderson, Karen O., Richman, Stephen P., Hurley, Judith, Palos, Guadalupe, Valero, Vicente, Mendoza, Tito R., Gning, Ibrahima, Cleeland, Charles S.

Volltext

Minority cancer patients and their providers von Anderson, Karen O., Mendoza, Tito R., Valero, Vicente, Richman, Stephen P., Russell, Christy, Hurley, Judith, DeLeon, Cindy, Washington, Patricia, Palos, Guadalupe, Payne, Richard, Cleeland, Charles S.

Volltext

Phase I trial of low dose N‐phosphonacetyl‐L‐aspartic acid and high dose 5‐fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma... von Ardalan, Bach, Ucar, Antonio, Reddy, Rajender, Livingstone, Alan S., Markoe, Arnold, Schwade, James, Richman, Stephen P., Donofrio, Kim

Volltext

A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma : a Southwest Oncology Group Study von WHITEHEAD, R. P, WOLF, M. K, SOLANKI, D. L, HEMSTREET, G. P, BENEDETTO, P, RICHMAN, S. P, FLANIGAN, R. C, CRAWFORD, E. D

Volltext

A phase II multi‐institutional trial of low‐dose N‐(phosphonacetyl)‐L‐aspartate and high‐dose 5‐fluorouracil as a short‐term infusion in the treatment of adenocarcinoma of the panc... von Morrell, Louise M., Bach, Ardalan, Richman, Stephen P., Goodman, Phyllis, Fleming, Thomas R., Macdonald, John S.

Volltext

Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-Fluorouracil in advanced gastric adenocarcinoma : A Southwest Oncology Gro... von MANINO, R. L, FLEMING, T. R, MORRELL, L. M, ARDALAN, B, RICHMAN, S. P, MACDONALD, J. S

Volltext

Phase II trial of trimetrexate in untreated advanced gastric carcinoma : a Southwest Oncology Group study von HANTEL, A, TANGEN, C. M, MACDONALD, J. S, RICHMAN, S. P, PUGH, R. P, POLLOCK, T

Volltext

Lung carcinoma in 1,336 patients von SRIDHAR, K. S, RAUB, W. JR, DUNCAN, R. C, HILSENBECK, S, RICHMAN, S. P

Volltext

High‐dose cisplatin in patients with advanced malignancies von Blumenreich, Martin S., Woodcock, Thomas M., Jones, Mariesa, Richman, Stephen P., Gentile, Patrick S., Kubota, Thomas T., Allegra, Joseph C.

Volltext